ArticleCureus2026
Facial Melanosis in Skin of Color: An Integrated Clinical, Dermoscopic, and Quality of Life Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFacial melanosis comprises a heterogeneous spectrum of pigmentary disorders that are particularly prevalent and persistent in skin of color. Despite its frequency, comprehensive data integrating clinical patterns, dermoscopic features, and quality of life impact remain limited, especially from Northeast India.
objectivesThis study aimed to characterize the clinical spectrum of facial melanosis, delineate dermoscopic patterns, including atypical features, and evaluate health-related quality of life using Skindex-16 in a skin of color population. MATERIALS AND
methodsThis hospital-based cross-sectional study included 150 untreated adults with facial melanosis. Participants underwent detailed clinical evaluation, dermoscopic assessment using a polarized video dermoscope, and quality of life assessment with Skindex-16. Diagnoses were classified as standalone or overlapping entities.
resultsTwenty-two clinical conditions were identified, with melasma being the most prevalent diagnosis (n = 102, 68.0%), showing a marked female preponderance. Overlapping presentations, particularly melasma with topical steroid damaged face (TSDF), were common. Dermoscopy revealed predominant pigmentary patterns such as brown structureless areas and globules, alongside vascular and appendageal changes. Importantly, infrequent atypical dermoscopic features, rarely reported in facial melanosis, were documented. Quality of life analysis demonstrated a disproportionate emotional burden despite relatively low symptom scores.
conclusionFacial melanosis in skin of color is clinically complex, frequently overlapping, and psychosocially impactful. The integration of dermoscopy and quality of life assessment provides a nuanced, patient-centered understanding, with the identification of atypical dermoscopic features representing a distinctive contribution of this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.